Skip to main content
Top
Published in: Heart and Vessels 4/2017

01-04-2017 | Original Article

A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis

Authors: Raisuke Iijima, Gjin Ndrepepa, Vivien Kujath, Yukinori Harada, Sebastian Kufner, Heribert Schunkert, Masato Nakamura, Adnan Kastrati

Published in: Heart and Vessels | Issue 4/2017

Login to get access

Abstract

The frequency and pattern of progression or regression of coronary atherosclerosis in contemporary patients with diabetes remain unknown. This study included 605 patients with coronary artery disease (CAD). Two coronary angiographic examinations at baseline and after 2 years were performed. The analysis focused on non-stented segments with diameter stenosis ≥25 %. Atherosclerosis progression (or regression) was defined as a decrease (or increase) in the mean minimal lumen diameter (MLD) in the 2-year angiogram compared to mean MLD in the baseline angiogram of >0.2 mm. Statins were prescribed in 576 patients (95.2 %). The primary outcome was atherosclerosis progression or regression in the 2-year angiogram. One hundred sixty-nine patients (28 %) had diabetes. Diabetic patients had greater reduction of mean MLD in the 24 angiogram compared to baseline angiogram than nondiabetic patients (0.11 ± 0.18 vs. −0.08 ± 0.15 mm, P < 0.001). Atherosclerosis progression was observed in 37 patients with diabetes and 16 nondiabetic patients (21.9 vs. 3.7 %; P < 0.001). Atherosclerosis regression was observed in two diabetic patients and 78 nondiabetic patients (1.2 vs. 17.9 %; P < 0.001). A progression pattern across all coronary segments was observed in 70 patients (41.4 %) with diabetes and 60 patients (13.8 %) without diabetes (P < 0.001). Diabetic patients with a low-density lipoprotein cholesterol ≥70 mg/dl showed more atherosclerosis progression than diabetic patients with LDL cholesterol <70 mg/dl (delta-MLD: 0.12 ± 0.19 vs. 0.08 ± 0.16 mm; P = 0.04). In conclusion, in contemporary patients with CAD treated with moderate-intensity statin therapy, diabetes is associated with the increased risk of progression and decreased probability of regression of coronary atherosclerosis.
Literature
1.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed
2.
go back to reference Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40:946–953CrossRefPubMed Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40:946–953CrossRefPubMed
3.
go back to reference Yun CH, Schlett CL, Rogers IS, Truong QA, Toepker M, Donnelly P, Brady TJ, Hoffmann U, Bamberg F (2009) Association between diabetes and different components of coronary atherosclerotic plaque burden as measured by coronary multidetector computed tomography. Atherosclerosis 205:481–485CrossRefPubMed Yun CH, Schlett CL, Rogers IS, Truong QA, Toepker M, Donnelly P, Brady TJ, Hoffmann U, Bamberg F (2009) Association between diabetes and different components of coronary atherosclerotic plaque burden as measured by coronary multidetector computed tomography. Atherosclerosis 205:481–485CrossRefPubMed
4.
go back to reference Boyle PJ (2007) Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med 120:S12–S17CrossRefPubMed Boyle PJ (2007) Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J Med 120:S12–S17CrossRefPubMed
5.
go back to reference Inaba S, Okayama H, Funada J, Higashi H, Saito M, Yoshii T, Hiasa G, Sumimoto T, Takata Y, Nishimura K, Inoue K, Ogimoto A, Higaki J (2012) Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging 13:717–723CrossRefPubMed Inaba S, Okayama H, Funada J, Higashi H, Saito M, Yoshii T, Hiasa G, Sumimoto T, Takata Y, Nishimura K, Inoue K, Ogimoto A, Higaki J (2012) Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging 13:717–723CrossRefPubMed
6.
go back to reference Schoenenberger AW, Jamshidi P, Kobza R, Zuber M, Stuck AE, Pfisterer M, Erne P (2010) Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II). Clin Cardiol 33:289–295CrossRefPubMed Schoenenberger AW, Jamshidi P, Kobza R, Zuber M, Stuck AE, Pfisterer M, Erne P (2010) Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II). Clin Cardiol 33:289–295CrossRefPubMed
7.
go back to reference Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I, Investigators T (2012) Impact of diabetes mellitus on coronary atherosclerosis and plaque composition under statin therapy—subanalysis of the TRUTH study. Circ J 76:2188–2196CrossRefPubMed Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I, Investigators T (2012) Impact of diabetes mellitus on coronary atherosclerosis and plaque composition under statin therapy—subanalysis of the TRUTH study. Circ J 76:2188–2196CrossRefPubMed
8.
go back to reference Saely CH, Rein P, Vonbank A, Huber K, Drexel H (2013) Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol 167:776–780CrossRefPubMed Saely CH, Rein P, Vonbank A, Huber K, Drexel H (2013) Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol 167:776–780CrossRefPubMed
9.
go back to reference Stegman B, Puri R, Cho L, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nissen SE, Nicholls SJ (2014) High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 37:3114–3120CrossRefPubMed Stegman B, Puri R, Cho L, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nissen SE, Nicholls SJ (2014) High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 37:3114–3120CrossRefPubMed
10.
go back to reference Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, Investigators C (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696CrossRefPubMed Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, Investigators C (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696CrossRefPubMed
11.
go back to reference Knopp RH, d’Emden M, Smilde JG, Pocock SJ (2006) Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 29:1478–1485CrossRefPubMed Knopp RH, d’Emden M, Smilde JG, Pocock SJ (2006) Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 29:1478–1485CrossRefPubMed
12.
go back to reference Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative G (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRefPubMed Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative G (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRefPubMed
13.
go back to reference Ndrepepa G, Iijima R, Kufner SSB, Cassese S, Byrne RA, Sorges J, Schulz-Schüpke S, Hoppmann P, Fusaro M, Laugwitz KL, Kastrati A (2016) Association of progression or regression of coronary artery atherosclerosis with long-term prognosis. Am Heart J 177:9–16CrossRefPubMed Ndrepepa G, Iijima R, Kufner SSB, Cassese S, Byrne RA, Sorges J, Schulz-Schüpke S, Hoppmann P, Fusaro M, Laugwitz KL, Kastrati A (2016) Association of progression or regression of coronary artery atherosclerosis with long-term prognosis. Am Heart J 177:9–16CrossRefPubMed
14.
go back to reference Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51:5–40CrossRefPubMed Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51:5–40CrossRefPubMed
15.
go back to reference Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE, Investigators A (2008) Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 117:2458–2466CrossRefPubMed Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE, Investigators A (2008) Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 117:2458–2466CrossRefPubMed
16.
go back to reference Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME (1995) Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. J Am Coll Cardiol 26:1133–1139CrossRefPubMed Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME (1995) Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. J Am Coll Cardiol 26:1133–1139CrossRefPubMed
17.
go back to reference Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255–262CrossRefPubMed Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255–262CrossRefPubMed
18.
go back to reference Stancoven A, McGuire DK (2007) Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond. Am J Cardiol 99:5H–11HCrossRefPubMed Stancoven A, McGuire DK (2007) Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond. Am J Cardiol 99:5H–11HCrossRefPubMed
19.
go back to reference Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852–1866CrossRefPubMed Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852–1866CrossRefPubMed
20.
go back to reference Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2889–2934CrossRefPubMed Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2889–2934CrossRefPubMed
21.
go back to reference Puri R, Nissen SE, Somaratne R, Cho L, Kastelein JP, Ballantyne CM, Koenig W, Anderson TJ, Yang J, Kassahun H, Wasserman SM, Scott R, Borgman M, Nissen SE (2016) Impact of PCSK9 inhibition on coronary atheroma progression: rationale and design of global assessment of plaque regression with a PCSK9 antibody as measured by intravascular ultrasound (GLAGOV). Am Heart J 176:83–92CrossRefPubMed Puri R, Nissen SE, Somaratne R, Cho L, Kastelein JP, Ballantyne CM, Koenig W, Anderson TJ, Yang J, Kassahun H, Wasserman SM, Scott R, Borgman M, Nissen SE (2016) Impact of PCSK9 inhibition on coronary atheroma progression: rationale and design of global assessment of plaque regression with a PCSK9 antibody as measured by intravascular ultrasound (GLAGOV). Am Heart J 176:83–92CrossRefPubMed
22.
go back to reference Nissen SE (2016) IVUS virtual histology unvalidated gimmick or useful technique? J Am Coll Cardiol 67:1784–1785CrossRefPubMed Nissen SE (2016) IVUS virtual histology unvalidated gimmick or useful technique? J Am Coll Cardiol 67:1784–1785CrossRefPubMed
23.
go back to reference Lansky AJ, Desai K, Leon MB (2002) Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations. Am J Cardiol 89:4b–9bCrossRefPubMed Lansky AJ, Desai K, Leon MB (2002) Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations. Am J Cardiol 89:4b–9bCrossRefPubMed
24.
go back to reference Nissen SE, Gurley JC (1991) Application of intravascular ultrasound for detection and quantitation of coronary atherosclerosis. Int J Card Imaging 6:165–177CrossRefPubMed Nissen SE, Gurley JC (1991) Application of intravascular ultrasound for detection and quantitation of coronary atherosclerosis. Int J Card Imaging 6:165–177CrossRefPubMed
Metadata
Title
A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis
Authors
Raisuke Iijima
Gjin Ndrepepa
Vivien Kujath
Yukinori Harada
Sebastian Kufner
Heribert Schunkert
Masato Nakamura
Adnan Kastrati
Publication date
01-04-2017
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 4/2017
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-016-0889-8

Other articles of this Issue 4/2017

Heart and Vessels 4/2017 Go to the issue